The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
MHC class I molecules and kirs in human history, health and survival
Abstract
MHC class I molecules are ligands for the killer-cell immunoglobulin-like receptors (KIRs), which are expressed by natural killer cells and T cells. The interactions between these molecules contribute to both innate and adaptive immunity. KIRs and MHC class I molecules are encoded by unlinked polymorphic gene families that distinguish all but the most related individuals. Combinations of MHC class I and KIR variants influence resistance to infections, susceptibility to autoimmune diseases and complications of pregnancy, as well as outcome after haematopoietic stem-cell transplantation. Such correlations raise the possibility that interplay between KIR and MHC class I polymorphisms has facilitated human survival in the presence of epidemic infections and has influenced both reproduction and population growth.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly significant differences were seen following genotyping of the mothers, suggesting a broad influence of the genetic background of NK activity, especially given that KIR/HLA complexes are expressed and active in the placenta (Guerini et al, 2014;Parham, 2005).”
From The Role of the Immune System in Autism Spectrum Disorder (2017) · cites this paper as Parham, 2005
Citations
Cites
Initial sequencing and comparative analysis of the mouse genome
Mouse Genome Sequencing Consortium (2002) · Nature · doi:10.1038/nature01262 · Cited by 7,187
Of Mice and Not Men: Differences between Mouse and Human Immunology
Mestas, J., & Hughes, C. C. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2731 · Cited by 3,822
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380
Natural killer cells and pregnancy
Moffett-King, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri886 · Cited by 1,235
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C., Gao, X., Astemborski, J. A., Cheng, J., Goedert, J. J., Vlahov, D., Hilgartner, M. W., et al. (2004) · Science · doi:10.1126/science.1097670 · Cited by 1,178
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS
Martin, M. P., Gao, X., Lee, J.-H., Nelson, G. W., Detels, R., Goedert, J. J., Buchbinder, S., Hoots, K. W., Vlahov, D., Trowsdale, J., et al. (2002) · Nature Genetics · doi:10.1038/ng934 · Cited by 1,173
Hiby, S. E., Walker, J. J., O’Shaughnessy, K. M., Redman, C. W. G., Carrington, M. N., Trowsdale, J., & Moffett, A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041214 · Cited by 1,134
Human Diversity in Killer Cell Inhibitory Receptor Genes
Uhrberg, M., Valiante, N. M., Shum, B. P., Shilling, H. G., Lienert-Weidenbach, K., Corliss, B. C., Tyan, D. B., Lanier, L. L., & Parham, P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80394-5 · Cited by 1,060
Self-citationKIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive Immunity
Vilches, C., & Parham, P. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.092501.134942 · Cited by 984
Self-citationAshkar, A. A., Santo, J. P. D., & Croy, B. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.259 · Cited by 847
Cited by
Sorted by citations
Items 501–600 of 1,000
Ancient divergence of a complex family of immune-type receptor genes
Cannon, J. P., Haire, R. N., Mueller, M. G., Litman, R. T., Eason, D. D., Tinnemore, D., Amemiya, C. T., Ota, T., & Litman, G. W. (2006) · Immunogenetics · doi:10.1007/s00251-006-0112-7 · Cited by 30
Hellmann, I., Lim, S., Gelman, R. S., & Letvin, N. L. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002436 · Cited by 29
Allele-Specific Cytokine Responses at the HLA-C Locus: Implications for Psoriasis
Hundhausen, C., Bertoni, A., Mak, R. K. H., Botti, E., Meglio, P. D., Clop, A., Laggner, U., Chimenti, S., Hayday, A., Barker, J. N., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.378 · Cited by 29
HETEROGENEOUS IMMUNOLOGICAL LANDSCAPES AND MEDIEVAL PLAGUE:
Crespo, F. A., & Lawrenz, M. B. (2014) · The Medieval Globe · doi:10.5040/9781641899406.0012 · Cited by 29
Carlomagno, S., Falco, M., Bono, M., Alicata, C., Garbarino, L., Mazzocco, M., Moretta, L., Moretta, A., & Sivori, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00581 · Cited by 31
Maruthamuthu, S., Rajalingam, K., Kaur, N., Morvan, M. G., Soto, J., Lee, N., Kong, D., Hu, Z., Reyes, K. R., Ng, D., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.845474 · Cited by 29
Juvenile respiratory papillomatosis: Risk factors for severity
Rodier, C., Lapointe, A., Coutlée, F., Mayrand, M., Soglio, D. B. D., Roger, M., & Trottier, H. (2013) · Journal of Medical Virology · doi:10.1002/jmv.23615 · Cited by 29
Wu, G. ‐., Zhao, Y., Lai, X., Yang, K., Zhu, F., Zhang, W., Wang, W., Luo, Y., Tan, Y., Wang, Y., et al. (2009) · Tissue Antigens · doi:10.1111/j.1399-0039.2009.01366.x · Cited by 29
Rölleke, U., Flügge, G., Plehm, S., Schlumbohm, C., Armstrong, V. W., Dressel, R., Uchańska‐Ziegler, B., Ziegler, A., Fuchs, E., Czéh, B., et al. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.04.015 · Cited by 29
Nowak, I., Malinowski, A., Tchórzewski, H., Barcz, E., Wilczyński, J. R., Banasik, M., Gryboś, M., Kurpisz, M. K., Łuszczek, W., Majorczyk, E., et al. (2010) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2010.11.001 · Cited by 29
Phillips, L., Gould, E. A., Babu, H., Krams, S. M., Palmer, T. D., & Martinez, O. M. (2013) · Stem Cells · doi:10.1002/stem.1422 · Cited by 29
KIR2DS3 is associated with protection against acute myeloid leukemia.
Shahsavar, F., Tajik, N., Entezami, K. Z., Radjabzadeh, M. F., Asadifar, B., Alimoghaddam, K., Ostadali, M., Jalali, A., Ghashghaie, A., & Ghavamzadeh, A. (2010) · PubMed · doi:10.22034/iji.2010.17035 · Cited by 29
Littera, R., Chessa, L., Onali, S., Figorilli, F., Lai, S., Secci, L., Nasa, G. L., Caocci, G., Arras, M., Melis, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146086 · Cited by 31
Pathogen selection drives nonoverlapping associations between HLA loci
Penman, B. S., Ashby, B., Buckee, C. O., & Gupta, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304218110 · Cited by 28
Blokhuis, J. H., van der Wiel, M. K. H., Doxiadis, G. G. M., & Bontrop, R. E. (2011) · European Journal of Immunology · doi:10.1002/eji.201141621 · Cited by 28
Tajik, N., Shahsavar, F., Poormoghim, H., Radjabzadeh, M. F., Mousavi, T., & Jalali, A. (2011) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2011.01024.x · Cited by 28
Nowak, I., Magott-Procelewska, M., Agnieszka, K., Maciej, M., Wagner, M., Niepiekło-Miniewska, W., Małgorzata, K., Wiśniewski, A., Majorczyk, E., Klinger, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044718 · Cited by 28
Kreutzman, A. S., Jaatinen, T., Greco, D., Vakkila, E., Richter, J., Ekblom, M., Hjorth‐Hansen, H., Stenke, L., Melo, T., Paquette, R. L., et al. (2012) · Experimental Hematology · doi:10.1016/j.exphem.2012.07.007 · Cited by 28
Zhi, D., Sun, C., Sedimbi, S. K., Luo, F., Shen, S., & Sanjeevi, C. B. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1264 · Cited by 28
NK Cells and their Receptors during Viral Infections
Marcenaro, E., Carlomagno, S., Pesce, S., Chiesa, M. D., Parolini, S., Moretta, A., & Sivori, S. (2011) · Immunotherapy · doi:10.2217/imt.11.99 · Cited by 28
Genetics of Risk Factors for Graft-Versus-Host Disease
Petersdorf, E. W., & Malkki, M. (2006) · Seminars in Hematology · doi:10.1053/j.seminhematol.2005.09.002 · Cited by 28
The Interplay between Natural Killer Cells and Human Herpesvirus-6
Eliassen, E., Luca, D. D., Rizzo, R., & Barão, I. (2017) · Viruses · doi:10.3390/v9120367 · Cited by 28
HLA-C downregulation by HIV-1 adapts to host HLA genotype
Bachtel, N. D., Umviligihozo, G., Pickering, S., Mota, T. M., Liang, H., Prete, G. Q. D., Chatterjee, P., Lee, G. Q., Thomas, R., Brockman, M. A., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007257 · Cited by 28
Conserved and variable natural killer cell receptors: diverse approaches to viral infections
Bastidas-Legarda, L. Y., & Khakoo, S. I. (2018) · Immunology · doi:10.1111/imm.13039 · Cited by 28
Kim, K. H., Yu, H. T., Hwang, I., Park, S., Park, S., Kim, S., & Shin, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02865 · Cited by 28
Immunological role and underlying mechanisms of B7‐H6 in tumorigenesis
Hu, Y., Zeng, T., Zheng, X. W., Hu, Q.-H., Li, Y., Tan, X., Yue, H., Wang, W., Tan, H., & Zou, J. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.12.030 · Cited by 28
Kielczewska, A., Kim, H.-S., Lanier, L. L., Dimasi, N., & Vidal, S. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.369 · Cited by 28
Nasa, G. L., Littera, R., Locatelli, F., Giardini, C., Ventrella, A., Mulargia, M., Vacca, A., Orrù, N., Orrù, S., Piras, E., et al. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2007.07.011 · Cited by 28
Bonorino, P., Leroy, V., Dufeu‐Duchesne, T., Tongiani-Dashan, S., Stürm, N., Pernollet, M., Vivier, É., Zarski, J., Marche, P. N., & Jouvin‐Marche, E. (2007) · Hepatology · doi:10.1002/hep.21850 · Cited by 28
Maternal–Fetal Compatibility in Recurrent Pregnancy Loss
Cuadrado-Torroglosa, I., García-Velasco, J. A., & Alecsandru, D. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13082379 · Cited by 30
Aversa, F., Martelli, M. F., & Velardi, A. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.09.002 · Cited by 27
Significance of KIR like natural killer cell receptors in autoimmune disorders
Agrawal, S., & Prakash, S. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108449 · Cited by 28
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications
Sportoletti, P., Falco, F. D., Papa, B. D., Baldoni, S., Guarente, V., Marra, A., Dorillo, E., Rompietti, C., Adamo, F. M., Ruggeri, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136665 · Cited by 29
Understanding natural killer cell biology from a single cell perspective
Subedi, N., Verhagen, L. P., Bosman, E. M., van Roessel, I., & Tel, J. (2022) · Cellular Immunology · doi:10.1016/j.cellimm.2022.104497 · Cited by 31
Kim, H. J., Choi, H.-B., Jang, J.-P., Baek, I., Choi, E., Park, M., Kim, T., & Oh, S. (2014) · International Journal of Surgery · doi:10.1016/j.ijsu.2014.06.012 · Cited by 27
Sivori, S., Falco, M., Moretta, L., & Moretta, A. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.05.007 · Cited by 26
Solomon, C., Southwood, S., Hoof, I., Rudersdorf, R. A., Peters, B., Sidney, J., Pinilla, C., Marcondes, M. C. G., Ling, B., Marx, P. A., et al. (2010) · Immunogenetics · doi:10.1007/s00251-010-0450-3 · Cited by 26
Neuchel, C., Furst, D. E., Niederwieser, D. W., Bunjes, D. W., Tsamadou, C., Wulf, G. G., Pfreundschuh, M. G., Wagner, E. M., Stuhler, G., Einsele, H., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169512 · Cited by 26
Zajonc, D. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207561 · Cited by 26
Piotrowska, M., Spodzieja, M., Kuncewicz, K., Rodziewicz‐Motowidło, S., & Orlikowska, M. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113694 · Cited by 26
Daull, A.-M., Dubois, V., Labussière‐Wallet, H., Venet, F., Barraco, F., Ducastelle-Leprêtre, S., Larcher, M., Balsat, M., Gilis, L., Fossard, G., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.841470 · Cited by 26
Cord Blood-Derived Natural Killer Cell Exploitation in Immunotherapy Protocols: More Than a Promise?
Damele, L., Spaggiari, G. M., Parodi, M., Mingari, M. C., Vitale, M., & Vitale, C. (2022) · Cancers · doi:10.3390/cancers14184439 · Cited by 26
Hanvesakul, R., Kubal, C. A., Moore, J., Neil, D., Cook, M. A., Ball, S. T., Briggs, D., Moss, P. A. H., & Cockwell, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023631 · Cited by 26
KIR2DS5 in the presence of HLA-C C2 protects against endometriosis
Nowak, I., Płoski, R., Barcz, E., Dziunycz, P., Kamiński, P., Kostrzewa, G., Milewski, Ł., Roszkowski, P. I., Senitzer, D., Malejczyk, J., et al. (2015) · Immunogenetics · doi:10.1007/s00251-015-0828-3 · Cited by 26
HLA-A Alleles and the Risk of Cervical Squamous Cell Carcinoma in Japanese Women
Hosono, S., Kawase, T., Matsuo, K., Watanabe, M., Kajiyama, H., Hirose, K., Suzuki, T., Kidokoro, K., Ito, H. M., Nakanishi, T., et al. (2010) · Journal of Epidemiology · doi:10.2188/jea.je20090155 · Cited by 26
Feuchtinger, T. F., Pfeiffer, M. M., Pfäffle, A., Teltschik, H.-M., Wernet, D., Schumm, M., Lotfi, R., Handgretinger, R., & Lang, P. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.398 · Cited by 26
Kiani, Z., Bruneau, J., Geraghty, D. E., & Bernard, N. F. (2019) · Journal of Virology · doi:10.1128/jvi.00933-19 · Cited by 26
Investigation of KIR Gene Frequencies in Type 1 Diabetes Mellitus
Middleton, D., Halfpenny, I. A., Meenagh, A., Williams, F., Sivula, J., & Tuomilehto‐Wolf, E. (2006) · Human Immunology · doi:10.1016/j.humimm.2006.08.295 · Cited by 26
Zaghi, E., Calvi, M., Vito, C. D., & Mavilio, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02794 · Cited by 25
Kaur, G., Porter, C. B. M., Ashenberg, O., Lee, J., Riesenfeld, S. J., Hofree, M., Aggelakopoulou, M., Subramanian, A., Kuttikkatte, S. B., Attfield, K. E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32171-w · Cited by 27
Killer cell immunoglobulin-like receptor (KIR) genes in systemic sclerosis
Salim, P. H., Jobim, M., Bredemeier, M., Chies, J. A. B., Schlottfeldt, J. L., Brenol, J. C. T., Jobim, L. F. J., & Xavier, R. M. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04095.x · Cited by 25
Wai, L., Garcia, J. A., Martinez, O. M., & Krams, S. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002597 · Cited by 25
Levinson, R. D., Okada, A. A., Ashouri, E., Keino, H., & Rajalingam, R. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.11.001 · Cited by 25
Jennes, W., Verheyden, S. J., Demanet, C. J., Menten, J., Vuylsteke, B., Nkengasong, J. N., & Kestens, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017043 · Cited by 25
Immunology of Hematopoietic Stem Cell Transplant
Mosaad, Y. M. (2014) · Immunological Investigations · doi:10.3109/08820139.2014.942460 · Cited by 25
Role of alloreactive KIR2DS1+ NK cells in haploidentical hematopoietic stem cell transplantation
Marcenaro, E., Carlomagno, S., Pesce, S., Chiesa, M. D., Moretta, A., & Sivori, S. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0311137 · Cited by 25
Vejbaesya, S., Thongpradit, R., Kalayanarooj, S., Luangtrakool, K., Luangtrakool, P., Gibbons, R. V., Srinak, D., Ngammthaworn, S., Apisawes, K., Yoon, I., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv127 · Cited by 25
Fedoseeva, L. A., Ryazanova, M. A., Ershov, N., Markel, А. L., & Redina, O. E. (2016) · BMC Genetics · doi:10.1186/s12863-015-0306-9 · Cited by 26
Suppression of HIV Replication by CD8+ Regulatory T-Cells in Elite Controllers
Lu, W., Chen, S., Lai, C., Lai, M., Hua, F., Dao, H., Kang, J. G., Fan, J., Guo, W., Fu, L., et al. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00134 · Cited by 25
Regulation of porcine classical and nonclassical MHC class I expression
Tennant, L. M., Renard, C., Chardon, P., & Powell, P. P. (2007) · Immunogenetics · doi:10.1007/s00251-007-0206-x · Cited by 25
MRI-guided immunotherapy development for multiple sclerosis in a primate
Hart, B. A. ‘., Smith, P., Amor, S., Strijkers, G. J., & Blezer, E. L. A. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03673-1 · Cited by 25
CTLA-4 antibodies: new directions, new combinations.
Funt, S. A., Page, D. B., Wolchok, J. D., & Postow, M. A. (2014) · PubMed · Cited by 24
Decreased HLA-C1 alleles in couples of KIR2DL2 positive women with recurrent pregnancy loss
Yang, X., Yang, E., Wang, W., He, Q., Jubiz, G., Katukurundage, D., Dambaeva, S. V., Beaman, K. D., & Kwak-Kim, J. Y.-H. (2020) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2020.103186 · Cited by 24
Early evaluation of natural killer activity in post-transplant acute myeloid leukemia patients
Pittari, G., Fregni, G., Roguet, L., Garcia, A., Vataire, A.-L., Wittnebel, S., Amsellem, S., Chouaı̈b, S., Bourhis, J.-H., & Caignard, A. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.265 · Cited by 24
Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells
Cognet, C., Farnarier, C., Gauthier, L., Frassati, C., André, P., Magérus, A., Anfossi, N., Rieux‐Laucat, F., Vivier, É., & SCHLEINITZ, N. (2010) · Clinical Immunology · doi:10.1016/j.clim.2009.12.009 · Cited by 24
Limaye, N., Belobrajdic, K., Wandstrat, A. E., Bonhomme, F., Edwards, S. V., & Wakeland, E. K. (2007) · Genes and Immunity · doi:10.1038/sj.gene.6364446 · Cited by 24
qKAT: a high-throughput qPCR method for KIR gene copy number and haplotype determination
Jiang, W., Johnson, C., Simecek, N., López-Álvarez, M. R., Di, D., Trowsdale, J., & Traherne, J. A. (2016) · Genome Medicine · doi:10.1186/s13073-016-0358-0 · Cited by 24
Erp, J. M. K., van de Graaf, E. A., Paantjens, A. W. M., van Ginkel, W. G. J., Schellekens, J., van Kessel, D. A., van den Bosch, J. M. M., & Otten, H. G. (2008) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2008.06.006 · Cited by 24
NKp44 expression, phylogenesis and function in non-human primate NK cells
Maria, A. D., Ugolotti, E., Rutjens, E., Mazza, S., Radic, L., Faravelli, A., Koopman, G., Marco, E. D., Costa, P., Ensoli, B., et al. (2009) · International Immunology · doi:10.1093/intimm/dxn144 · Cited by 24
Impact of Recipient HLA-C in Liver Transplant: A Protective Effect of HLA-Cw*07 on Acute Rejection
Moya‐Quiles, M. R., Alvarez, R., Miras, M., Gómez-Mateo, J., López-Álvarez, M. R., Marin-Moreno, I., Martínez‐Barba, E., Sanchez-Mozo, M. P. S., Gomez, M., Arnal, F. M., et al. (2006) · Human Immunology · doi:10.1016/j.humimm.2006.10.009 · Cited by 24
Potential therapeutic role of natural killer cells in cancer
Woan, K. V., & Reddy, V. S. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.1.17 · Cited by 24
The Biological Influence and Clinical Relevance of Polymorphism Within the NKG2D Ligands
Zuo, J., Mohammed, F., & Moss, P. A. H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01820 · Cited by 23
KIR/HLA genotypes confer susceptibility and progression in patients with autoimmune hepatitis
Umemura, T., Joshita, S., Saito, H., Yoshizawa, K., Norman, G. L., Tanaka, E., & Ôta, M. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.09.003 · Cited by 23
Giardino, S., Bagnasco, F., Falco, M., Miano, M., Pierri, F., Risso, M., Terranova, P., Martino, D. D., Massaccesi, E., Ricci, M., et al. (2022) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2022.04.002 · Cited by 23
The killer‐cell immunoglobulin‐like receptors of macaques
Bimber, B. N., & Evans, D. T. (2015) · Immunological Reviews · doi:10.1111/imr.12329 · Cited by 23
Willemze, R., Ruggeri, A., Purtill, D., Arrais‐Rodrigues, C., Gluckman, É., & Rocha, V. (2010) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2010.05.005 · Cited by 23
A Role for KIR Gene Variants Other Than KIR2DS1 in Conferring Susceptibility to Psoriasis
Płoski, R., Łuszczek, W., Kuśnierczyk, P., Nockowski, P., Cisło, M., Krajewski, P., & Malejczyk, J. (2006) · Human Immunology · doi:10.1016/j.humimm.2006.04.001 · Cited by 23
Receptor systems controlling natural killer cell function are genetically stratified in Europe
Guinan, K. J., Cunningham, R. T., Meenagh, A., Dring, M. M., Middleton, D., & Gardiner, C. M. (2009) · Genes and Immunity · doi:10.1038/gene.2009.60 · Cited by 23
Şahin, U., Dalva, K., Gungor, F., Üstün, C., & Beksaç, M. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3274-0 · Cited by 23
Augusto, D. G., Norman, P. J., Dandekar, R., & Hollenbach, J. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00989 · Cited by 24
Vineretsky, K. A., Karagas, M. R., Christensen, B. C., Kuriger, J. K., Perry, A. E., Storm, C. A., & Nelson, H. H. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-0547 · Cited by 23
Nowak, I., Malinowski, A., Tchórzewski, H., Barcz, E., Wilczyński, J. R., Gryboś, M., Kurpisz, M. K., Łuszczek, W., Banasik, M., Reszczyńska-Ślęzak, D., et al. (2009) · Journal of Applied Genetics · doi:10.1007/bf03195699 · Cited by 23
Immunotherapy – Strategies for Expanding Its Role in the Treatment of All Major Tumor Sites
Sanghera, C., & Sanghera, R. (2019) · Cureus · doi:10.7759/cureus.5938 · Cited by 23
Zhuang, X., & Long, E. O. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.840844 · Cited by 22
Regulation of HLA class I expression by non-coding gene variations
Bettens, F., Ongen, H., Rey, G., Bühler, S., Sollet, Z. C., Dermitzakis, E. T., & Villard, J. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010212 · Cited by 22
Immunological Aspects of Infertility—The Role of KIR Receptors and HLA-C Antigen
Wasilewska, A., Grabowska, M., Moskalik-Kierat, D., Brzoza, M., Laudański, P., & Garley, M. (2023) · Cells · doi:10.3390/cells13010059 · Cited by 22
Extranodal NK/T‐Cell Lymphoma: Toward the Identification of Clinical Molecular Targets
Schmitt, C., Sako, N., Bagot, M., Huang, Y., Gaulard, P., & Bensussan, A. (2011) · BioMed Research International · doi:10.1155/2011/790871 · Cited by 22
Steiner, N., Dakshanamurthy, S., VandenBussche, C. J., & Hurley, C. K. (2008) · Immunogenetics · doi:10.1007/s00251-008-0322-2 · Cited by 22
López-Álvarez, M. R., Moya‐Quiles, M. R., Minguela, A., Gil, J., Miras, M., Campillo, J. A., Díaz-Alderete, M. A., García-Alonso, A. M., Bueno, F. S., Vicario, J. L., et al. (2009) · Transplantation · doi:10.1097/tp.0b013e3181af7d84 · Cited by 22
Alomar, S. Y., ALKHURIJI, A. F., Trayhyrn, P., Alhetheel, A., AlJurayyan, A. N., & Mansour, L. A. (2016) · Immunogenetics · doi:10.1007/s00251-016-0950-x · Cited by 22
mountainClimber Identifies Alternative Transcription Start and Polyadenylation Sites in RNA-Seq
Cass, A. A., & Xiao, X. G. (2019) · Cell Systems · doi:10.1016/j.cels.2019.07.011 · Cited by 22
Verneris, M. R., Miller, J. S., Hsu, K. C., Wang, T., Sees, J. A., Paczesny, S., Rangarajan, H. G., Lee, D. A., Spellman, S. R., & Lee, S. J. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019001284 · Cited by 22
NK Cell-Based Immunotherapy and Therapeutic Perspective in Gliomas
Pan, C., Zhai, Y., Li, G., Jiang, T., & Zhang, W. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.751183 · Cited by 23
Horvath‐Arcidiacono, J. A., Porter, C. M., & Bloom, E. T. (2006) · Xenotransplantation · doi:10.1111/j.1399-3089.2006.00316.x · Cited by 22
Polymorphisms of killer immunoglobulin-like receptors (KIRs) and HLA ligands in northeastern Thais
Chaisri, S., Kitcharoen, K., Romphruk, A. V., Romphruk, A., Witt, C. S., & Leelayuwat, C. (2013) · Immunogenetics · doi:10.1007/s00251-013-0716-7 · Cited by 22
Kimoto, Y., Horiuchi, T., Tsukamoto, H., Kiyohara, C., Mitoma, H., Uchino, A., Furugo, I., Yoshizawa, S., Ueda, A., Harashima, S., et al. (2010) · Rheumatology · doi:10.1093/rheumatology/keq050 · Cited by 22
Müller-Durovic, B., Gasser, O., Gubser, P. M., Sigle, J. M., Hirsch, H. H., Stern, M., Buser, A. S., & Hess, C. (2013) · Journal of Virology · doi:10.1128/jvi.00169-13 · Cited by 22
Martínez‐Sánchez, M. V., Periago, A., Legáz, I., Gimeno, L., Mrowiec, A., Montes-Barqueros, N. R., Campillo, J. A., Bolarín, J. M., Bernardo, M. V., López-Álvarez, M. R., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1093721 · Cited by 22
Sea squirts and immune tolerance
Tomaso, A. W. D. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.001156 · Cited by 22
Essat, A., Chapel, A., Amocrane, K., Monceaux, V., Didier, C., Mélard, A., Gardiennet, E., Avettand-Fènoël, V., Orr, S., Boufassa, F., et al. (2025) · Med · doi:10.1016/j.medj.2025.100670 · Cited by 23
Metadata
- Authors
- Parham, P.
- Affiliations
- Stanford University (US)
- Corresponding author
- Parham, Peter
- ORCID
- Parham, Peter
- Venue
- Nature Reviews Immunology
- Published
- 2005-02-18
- Volume
- 5
- Issue
- 3
- Pages
- 201-214
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2008919922
- Cited by
- 1,203
- References
- 125
- Citations by year
- 2026: 28 · 2025: 36 · 2024: 35 · 2023: 23 · 2022: 44 · 2021: 38 · 2020: 43 · 2019: 54 · 2018: 46 · 2017: 50 · 2016: 57 · 2015: 55 · 2014: 57 · 2013: 95 · 2012: 77
- FWCI
- 5.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- MHC class I, killer cell immunoglobulin-like receptors, natural killer cells, T cells, infection resistance, autoimmune disease susceptibility, pregnancy complications, hematopoietic stem cell transplantation, human survival, immune system evolution, reproduction
- MeSH terms
- Animals, Autoimmune Diseases, Communicable Diseases, Humans, Lymphocytes, Neoplasms, Receptors, Immunologic, Histocompatibility Antigens Class I, Models, Immunological, Evolution, Molecular, Receptors, KIR
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review